Novartis, Emirates Dermatology Society renew partnership for enhanced skin care

UAE—Novartis, a global leader in innovative medicines, and the Emirates Dermatology Society (EDS) have renewed their partnership to transform dermatological care in the United Arab Emirates (UAE).

Now entering its third year, this collaboration focuses on high-impact immunological skin diseases such as Psoriasis, Hidradenitis Suppurativa (HS), and Chronic Spontaneous Urticaria (CSU).

Their shared mission is to close diagnostic gaps and enhance patients’ quality of life by ensuring faster, more accurate diagnoses and improved treatment outcomes.

Despite significant advances in dermatology, there remains a critical need to accelerate diagnosis and care for patients across the UAE.

Skin conditions like Psoriasis, HS, and CSU not only cause physical discomfort but also deeply affect mental health, often leading to anxiety, depression, and social isolation. This highlights the necessity for timely, compassionate, and comprehensive care.

To clarify, CSU is a chronic condition characterized by persistent hives lasting six weeks or more, which can appear without clear triggers and cause intense itching and discomfort.

HS involves recurrent, painful lumps beneath the skin that may inflame, rupture, and result in scarring.

Psoriasis is an autoimmune disorder marked by thick, red, scaly skin plaques that can be itchy and painful.

Each of these chronic inflammatory diseases presents unique clinical challenges and significantly impacts patients’ daily lives.

The partnership between Novartis and EDS is dedicated to addressing these challenges through evidence-based solutions.

Dr. Ayman Alnaeem, President of the Emirates Dermatology Society, emphasized that the collaboration aims to proactively overcome barriers to care by helping physicians recognize these conditions earlier, ensuring patients receive timely treatment and improved well-being.

Mohamed Ezz Eldin, Head of GCC at Novartis, added that their commitment to reimagining medicine drives this alliance.

Together, they are building a healthcare ecosystem in the Gulf region where personalized, timely care leads to better patient outcomes.

The Emirates Dermatology Society plays a vital role in shaping the future of dermatological care in the UAE.

With an active management committee, EDS connects dermatologists, promotes knowledge sharing, and fosters excellence in the field.

Dr. Raghda Al Maashari, Cultural Committee Chairperson at EDS, highlighted that the partnership enables dermatologists to collaborate and translate global innovations into local solutions.

Novartis and EDS reaffirm their shared vision of a future where every patient has access to timely diagnosis, personalized treatment, and an improved quality of life.

This ongoing collaboration not only raises awareness but also supports healthcare providers and policymakers in delivering better care to those affected by these chronic skin diseases.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.